A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
Clinical trial NCT07053423 · RECRUITING
Trial details
- NCT number
- NCT07053423
- Sponsor
- Sanofi
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-22
- Primary completion
- 2028-12-23
- Enrollment
- 218
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.